全文获取类型
收费全文 | 36125篇 |
免费 | 3889篇 |
国内免费 | 62篇 |
专业分类
耳鼻咽喉 | 218篇 |
儿科学 | 1196篇 |
妇产科学 | 983篇 |
基础医学 | 4952篇 |
口腔科学 | 724篇 |
临床医学 | 4419篇 |
内科学 | 6766篇 |
皮肤病学 | 603篇 |
神经病学 | 3188篇 |
特种医学 | 1684篇 |
外国民族医学 | 3篇 |
外科学 | 4585篇 |
综合类 | 786篇 |
一般理论 | 43篇 |
预防医学 | 4293篇 |
眼科学 | 897篇 |
药学 | 2634篇 |
中国医学 | 46篇 |
肿瘤学 | 2056篇 |
出版年
2022年 | 280篇 |
2021年 | 634篇 |
2020年 | 416篇 |
2019年 | 584篇 |
2018年 | 685篇 |
2017年 | 531篇 |
2016年 | 579篇 |
2015年 | 602篇 |
2014年 | 852篇 |
2013年 | 1240篇 |
2012年 | 1672篇 |
2011年 | 1630篇 |
2010年 | 1005篇 |
2009年 | 943篇 |
2008年 | 1487篇 |
2007年 | 1574篇 |
2006年 | 1569篇 |
2005年 | 1488篇 |
2004年 | 1442篇 |
2003年 | 1349篇 |
2002年 | 1285篇 |
2001年 | 1215篇 |
2000年 | 1214篇 |
1999年 | 1051篇 |
1998年 | 498篇 |
1997年 | 470篇 |
1996年 | 431篇 |
1995年 | 365篇 |
1994年 | 377篇 |
1993年 | 371篇 |
1992年 | 839篇 |
1991年 | 794篇 |
1990年 | 792篇 |
1989年 | 718篇 |
1988年 | 729篇 |
1987年 | 672篇 |
1986年 | 615篇 |
1985年 | 677篇 |
1984年 | 550篇 |
1983年 | 426篇 |
1982年 | 278篇 |
1981年 | 294篇 |
1980年 | 267篇 |
1979年 | 470篇 |
1978年 | 351篇 |
1977年 | 265篇 |
1976年 | 280篇 |
1974年 | 288篇 |
1973年 | 263篇 |
1972年 | 269篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Jenny U. Johansson Nathaniel S. Woodling Qian Wang Maharshi Panchal Xibin Liang Angel Trueba-Saiz Holden D. Brown Siddhita D. Mhatre Taylor Loui Katrin I. Andreasson 《The Journal of clinical investigation》2015,125(1):350-364
Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer’s disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine models that recapitulate microglial responses to Aβ peptides and determined that microglia-specific deletion of the gene encoding the PGE2 receptor EP2 restores microglial chemotaxis and Aβ clearance, suppresses toxic inflammation, increases cytoprotective insulin-like growth factor 1 (IGF1) signaling, and prevents synaptic injury and memory deficits. Our findings indicate that EP2 signaling suppresses beneficial microglia functions that falter during AD development and suggest that inhibition of the COX/PGE2/EP2 immune pathway has potential as a strategy to restore healthy microglial function and prevent progression to AD. 相似文献
4.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
5.
6.
7.
La Creis R Kidd K Woodson P R Taylor D Albanes J Virtamo J A Tangrea 《European journal of cancer prevention》2003,12(4):317-320
Glutathione-S-transferase (GST) genes encode a family of detoxification enzymes that offer protection against endogenous and exogenous sources of reactive oxygen species (ROS). Germline variations in GST genes may alter the catalytic efficiency of GST isoenzymes leading to a potential increase in susceptibility to the genotoxic effects of ROS and electrophilic substances. A nested case-control study design was used to examine the association between the polymorphic GST genes and prostate cancer risk among Finnish male smokers of the ATBC Cancer Prevention Study. A case-case analysis was used to determine the association between these genetic polymorphisms and prostate cancer progression. Germline DNA was obtained from 206 prostate cancer cases and 194 controls frequency matched on age, intervention group and study clinic. Cases and controls were genotyped for three GST genes using MALDI-TOF mass spectrometry or multiplex polymerase chain reaction (PCR). Relative to the wild-type genotype, we observed a 36% reduction in prostate cancer risk associated with the GST-M1-null genotype (odds ratio (OR) 0.64, 95% confidence interval (CI) 0.43, 0.95). Unlike GST-M1, GST-T1-null (OR 0.74, 95% CI 0.42, 1.33) and GST-P1*B (OR 1.10, 95% CI 0.72, 1.69) were not strongly associated with prostate cancer risk. We did not observe any significant associations between the selected polymorphic GST genes and tumour grade or stage. In conclusion, we did not observe a direct association between polymorphic GST-T1 or GST-P1 and prostate cancer risk. Our observation of a relatively strong inverse association between the GST-M1-null genotype and prostate cancer risk needs to be confirmed in larger association studies. 相似文献
8.
C M Taylor 《Archives of disease in childhood》2006,91(3):277-8; author reply 277-8
9.
Educating African American men about the prostate cancer screening dilemma: a randomized intervention. 总被引:1,自引:0,他引:1
Kathryn L Taylor Jackson L Davis Ralph O Turner Lenora Johnson Marc D Schwartz Jon F Kerner Chikarlo Leak 《Cancer epidemiology, biomarkers & prevention》2006,15(11):2179-2188
BACKGROUND: Until there is a definitive demonstration that early diagnosis and treatment of prostate cancer reduces disease-related mortality, it is imperative to promote informed screening decisions by providing balanced information about the potential benefits and risks of prostate cancer screening. Within a community/academic collaboration, we conducted a randomized trial of a printed booklet and a videotape that were designed for African American (AA) men. The purpose of the trial was to determine the effect of the interventions on knowledge, decisional conflict, satisfaction with the screening decision, and self-reported screening. METHODS: Participants were 238 AA men, ages 40 to 70 years, who were members of the Prince Hall Masons in Washington, DC. Men were randomly assigned to the (a) video-based information study arm, (b) print-based information study arm, or (c) wait list control study arm. Intervention materials were mailed to men at home. Assessments were conducted at baseline, 1 month, and 12 months postintervention. Multivariate analyses, including ANCOVA and logistic regression, were used to analyze group differences. RESULTS: The booklet and video resulted in a significant improvement in knowledge and a reduction in decisional conflict about prostate cancer screening, relative to the wait list control. Satisfaction with the screening decision was not affected by the interventions. Self-reported screening rates increased between the baseline and the 1-year assessment, although screening was not differentially associated with either of the interventions. In exploratory analyses, prostate-specific antigen testing at 1 year was more likely among previously screened men and was associated with having low baseline decisional conflict. CONCLUSIONS: This study represents one of the first randomized intervention trials specifically designed to address AA men's informed decision making about prostate cancer screening. We have developed and evaluated culturally sensitive, balanced, and disseminable materials that improved knowledge and reduced decisional conflict about prostate cancer screening among AA men. Due to the high incidence and mortality rates among AA men, there is a need for targeted educational materials, particularly materials that are balanced in terms of the benefits and risks of screening. 相似文献
10.